Literature DB >> 17224845

Genotypic resistance of archived and circulating viral strains in the blood of treated HIV-infected individuals.

Ombretta Turriziani1, Mauro Bucci, Armando Stano, Carolina Scagnolari, Francesca Bellomi, Caterina Fimiani, Ivano Mezzaroma, Gabriella D'Ettorre, Andrea Brogi, Vincenzo Vullo, Guido Antonelli.   

Abstract

The aim of this study was to evaluate patterns of antiretroviral resistance of HIV-1 in peripheral blood mononuclear cells (PBMCs) and in the plasma of patients whose therapeutic regimen is failing. Plasma and PBMC samples were collected from 95 HIV-infected patients undergoing long-term treatment. Genotyping of the reverse transcriptase (RT) and protease genes of HIV-1 was undertaken using the fluorescent dideoxy-terminator method. Comparison of the amino acid sequence of the RT and protease genes in cell-associated variants of HIV-1 with that of the plasma revealed that 62 of the 95 patients' samples tested exhibited different genotypic resistance patterns (discordant samples [DSs]). In 27% of samples, the patterns of resistance detected were concordant in both compartments. In 51% of DSs, the greatest number of mutations was found in plasma; however, in 37% of DSs, greater numbers of mutations were found in PBMC DNA. The HIV mutation patterns detected in plasma do not necessarily reflect those found in the cell-associated compartment. The observation that the cellular compartment may contain an archive of the resistance variant makes this reservoir an interesting substrate for analysis of the "resistance potential" in a given patient.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17224845     DOI: 10.1097/QAI.0b013e3180315515

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  10 in total

1.  Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.

Authors:  Silvia Baroncelli; Clementina Maria Galluzzo; Liliana Elena Weimer; Maria Franca Pirillo; Anna Volpe; Alessandra Mercuri; Albertina Cavalli; Vincenzo Fragola; Laura Monno; Anna Degli Antoni; Nicoletta Ladisa; Daniela Francisci; Raffaella Bucciardini; Marco Floridia
Journal:  J Antimicrob Chemother       Date:  2012-02-23       Impact factor: 5.790

2.  Complexity and dynamics of HIV-1 chemokine receptor usage in a multidrug-resistant adolescent.

Authors:  Mariangela Cavarelli; Lara Mainetti; Angela Rosa Pignataro; Alba Bigoloni; Monica Tolazzi; Andrea Galli; Silvia Nozza; Antonella Castagna; Michela Sampaolo; Enzo Boeri; Gabriella Scarlatti
Journal:  AIDS Res Hum Retroviruses       Date:  2014-12       Impact factor: 2.205

3.  New antiretroviral agent use affects prevalence of HIV drug resistance in clinical care populations.

Authors:  Thibaut Davy-Mendez; Joseph J Eron; Laurence Brunet; Oksana Zakharova; Ann M Dennis; Sonia Napravnik
Journal:  AIDS       Date:  2018-11-13       Impact factor: 4.177

4.  High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia.

Authors:  Rebecca Nedellec; Joshua T Herbeck; Peter W Hunt; Steven G Deeks; James I Mullins; Elizabeth D Anton; Jacqueline D Reeves; Donald E Mosier
Journal:  AIDS Res Hum Retroviruses       Date:  2016-10-12       Impact factor: 2.205

5.  Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients.

Authors:  Katia Monteleone; Pierluigi Di Maio; Giulia Cacciotti; Francesca Falasca; Maurizio Fraulo; Mario Falciano; Ivano Mezzaroma; Gabriella D'Ettorre; Ombretta Turriziani; Carolina Scagnolari
Journal:  Med Microbiol Immunol       Date:  2014-02-20       Impact factor: 3.402

6.  Prolonged and substantial discordance in prevalence of raltegravir-resistant HIV-1 in plasma versus PBMC samples revealed by 454 "deep" sequencing.

Authors:  Guinevere Q Lee; Luke C Swenson; Art F Y Poon; Jeffrey N Martin; Hiroyu Hatano; Steven G Deeks; P Richard Harrigan
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

7.  Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase.

Authors:  Mark J Siedner; Michelle A Moorhouse; Bryony Simmons; Tulio de Oliveira; Richard Lessells; Jennifer Giandhari; Stephen A Kemp; Benjamin Chimukangara; Godspower Akpomiemie; Celicia M Serenata; Willem D F Venter; Andrew Hill; Ravindra K Gupta
Journal:  Nat Commun       Date:  2020-12-01       Impact factor: 14.919

Review 8.  Overview of the Analytes Applied in Genotypic HIV Drug Resistance Testing.

Authors:  Hezhao Ji; Paul Sandstrom
Journal:  Pathogens       Date:  2022-06-29

9.  Long-Term Control of Human Immunodeficiency Virus-1 Replication Despite Extensive Resistance to Current Antiretroviral Regimens: Clonal Analysis of Resistance Mutations in Proviral Deoxyribonucleic Acid.

Authors:  Natalia Stella-Ascariz; Rocio Montejano; María Martin-Vicente; Jesús Mingorance; Ignacio Pérez-Valero; José I Bernardino; Jose R Arribas
Journal:  Open Forum Infect Dis       Date:  2016-02-19       Impact factor: 3.835

10.  HIV-1C proviral DNA for detection of drug resistance mutations.

Authors:  Kahsay Huruy; Andargachew Mulu; Uwe Gerd Liebert; Melanie Maier
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.